Influence of Treatment With the HMG-CoA-Reductase Inhibitor Fluvastatin on Erectile Function in Patients With Cardiovascular Risk-Factors and Erectile Dysfunction.

Trial Profile

Influence of Treatment With the HMG-CoA-Reductase Inhibitor Fluvastatin on Erectile Function in Patients With Cardiovascular Risk-Factors and Erectile Dysfunction.

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 29 Aug 2016

At a glance

  • Drugs Fluvastatin (Primary)
  • Indications Erectile dysfunction
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Jul 2012 New source identified and integrated (German Clinical Trials Register: DRKS00003988).
    • 12 Feb 2009 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 21 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top